175 / 386
20.1 Consolidated financial statements for the year ended December 31, 2016
FINANCIAL INFORMATION CONCERNING ASSETS,
FINANCIAL POSITION AND FINANCIAL PERFORMANCE
20
20.1.2.
CONSOLIDATED STATEMENT OF INCOME
(in millions of euros)
Note
2016
2015*
REVENUE
4
10
33
Other income from operations
1
-
Cost of sales
(419)
(950)
Gross margin
(408)
(917)
Research and development expenses
(13)
(13)
Marketing and sales expenses
(9)
(3)
General and administrative expenses
7
(126)
(88)
Other operating expenses
7
(80)
(274)
Other operating income
7
195
8
OPERATING INCOME
(442)
(1,287)
Share in net income of joint ventures and associates
14
(14)
(26)
Operating income after share in net income of joint ventures and associates
(456)
(1,314)
Income from cash and cash equivalents
38
87
Gross borrowing costs
(111)
(68)
Net borrowing costs
(73)
19
Other financial expenses
(33)
(77)
Other financial income
38
12
Other financial income and expenses
5
(65)
NET FINANCIAL INCOME
8
(68)
(46)
Income tax
9
118
93
NET INCOME FROM CONTINUING OPERATIONS
(405)
(1,267)
Net income from operations sold, discontinued or held for sale
3
(365)
(770)
NET INCOME FOR THE PERIOD
(770)
(2,036)
Including:
Group:
Net income from continuing operations
(405)
(1,267)
Net income from operations sold, discontinued or held for sale
(260)
(771)
NET INCOME ATTRIBUTABLE TO OWNERS OF THE PARENT
(665)
(2,038)
Minority interests:
Net income from continuing operations
0
0
Net income from operations sold, discontinued or held for sale
(105)
2
NET INCOME ATTRIBUTABLE TO MINORITY INTERESTS
(105)
2
Number of shares outstanding
383,204,852
383,204,852
Average number of shares outstanding
383,204,852
383,204,852
Average number of treasury shares
956,422
908,871
Average number of shares outstanding, excluding treasury shares
382,248,430
382,295,981
Earnings per share from continuing operations
(1.06)
(3.31)
Basic earnings per share
(1.74)
(5.33)
Net income attributable to owners of the parent per diluted share
(1)
(1.74)
(5.33)
(1) AREVA has not issued any instruments with a dilutive impact on capital.
* In application of IFRS 5, the 2015 financial statements were restated in relation to the data reported for the previous year. The impacts of these restatements are detailed in
note 37.
2016 AREVA
REFERENCE DOCUMENT
175